• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Further clinical data on the more rapid achievement of remission without the use of steroids with tocilizumab compared to methotrexate in giant-cell arteritis.

作者信息

Szarpak Lukasz, Cander Basar, Pruc Michal

机构信息

Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, One Baylor Plaza, BCM285, Houston, TX, 77030, USA.

Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.

出版信息

Intern Emerg Med. 2025 Jan;20(1):9-10. doi: 10.1007/s11739-024-03769-3. Epub 2024 Nov 4.

DOI:10.1007/s11739-024-03769-3
PMID:39495354
Abstract
摘要

相似文献

1
Further clinical data on the more rapid achievement of remission without the use of steroids with tocilizumab compared to methotrexate in giant-cell arteritis.与甲氨蝶呤相比，托珠单抗在巨细胞动脉炎中无需使用类固醇就能更快实现缓解的更多临床数据。
Intern Emerg Med. 2025 Jan;20(1):9-10. doi: 10.1007/s11739-024-03769-3. Epub 2024 Nov 4.
2
Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial.托珠单抗治疗巨细胞动脉炎患者的长期疗效：巨细胞动脉炎托珠单抗（GiACTA）试验的开放标签延长期
Lancet Rheumatol. 2021 May;3(5):e328-e336. doi: 10.1016/S2665-9913(21)00038-2. Epub 2021 Mar 19.
3
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.托珠单抗诱导和维持巨细胞动脉炎缓解的疗效：一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2016 May 7;387(10031):1921-7. doi: 10.1016/S0140-6736(16)00560-2. Epub 2016 Mar 4.
4
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study.托珠单抗两阶段递减疗程治疗巨细胞动脉炎的疗效：单中心前瞻性研究。
Semin Arthritis Rheum. 2023 Apr;59:152174. doi: 10.1016/j.semarthrit.2023.152174. Epub 2023 Feb 9.
5
[Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].托珠单抗在巨细胞动脉炎和主动脉炎中节省皮质类固醇的疗效及耐受性：尼姆大学医院关于11例患者的经验
Rev Med Interne. 2018 Feb;39(2):78-83. doi: 10.1016/j.revmed.2017.11.001. Epub 2017 Dec 6.
6
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres.托珠单抗与甲氨蝶呤相比可更快实现巨细胞动脉炎的无类固醇缓解：两个参考中心的真实经验。
Intern Emerg Med. 2024 Nov;19(8):2177-2184. doi: 10.1007/s11739-024-03722-4. Epub 2024 Aug 2.
7
The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.《Meteoritics 试验：托西珠单抗和糖皮质激素诱导缓解后甲氨蝶呤治疗巨细胞动脉炎的疗效：一项随机、双盲、安慰剂对照、平行分组 II 期研究方案》
Trials. 2024 Jan 15;25(1):56. doi: 10.1186/s13063-024-07905-4.
8
Tocilizumab for relapsing and remitting giant cell arteritis: a case series.托珠单抗治疗复发缓解型巨细胞动脉炎：病例系列研究。
J Med Case Rep. 2022 Oct 27;16(1):389. doi: 10.1186/s13256-022-03625-y.
9
Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept study.采用 8 周泼尼松联合托珠单抗治疗巨细胞动脉炎：一项单臂、开放标签、概念验证研究。
Lancet Rheumatol. 2023 Dec;5(12):e736-e742. doi: 10.1016/S2665-9913(23)00265-5. Epub 2023 Nov 2.
10
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study.托珠单抗与甲氨蝶呤治疗活动性巨细胞动脉炎患者队列的比较：一项临床与超声对比研究
Biologics. 2023 Dec 1;17:151-160. doi: 10.2147/BTT.S431818. eCollection 2023.

本文引用的文献

1
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres.托珠单抗与甲氨蝶呤相比可更快实现巨细胞动脉炎的无类固醇缓解：两个参考中心的真实经验。
Intern Emerg Med. 2024 Nov;19(8):2177-2184. doi: 10.1007/s11739-024-03722-4. Epub 2024 Aug 2.
2
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis.目标治疗策略对早期类风湿关节炎起始甲氨蝶呤、托珠单抗或两者联合治疗的成本和质量调整生命年的影响。
J Rheumatol. 2021 Apr;48(4):495-503. doi: 10.3899/jrheum.200067. Epub 2020 Aug 1.
3
Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials.
托珠单抗单药治疗对两项随机对照试验中类风湿关节炎患者报告结局的影响。
RMD Open. 2017 Sep 14;3(2):e000496. doi: 10.1136/rmdopen-2017-000496. eCollection 2017.
4
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis.托珠单抗，一种人源化抗白细胞介素-6受体抗体，用于治疗类风湿关节炎。
Open Access Rheumatol. 2011 Feb 25;3:19-29. doi: 10.2147/OARRR.S17118. eCollection 2011.